Next Article in Journal
Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance
Next Article in Special Issue
Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs
Previous Article in Journal
Vimentin Intermediate Filaments as Potential Target for Cancer Treatment
Previous Article in Special Issue
Deregulated NKL Homeobox Genes in B-Cell Lymphoma
Open AccessReview

Article Versions Notes

Cancers 2020, 12(1), 185; https://doi.org/10.3390/cancers12010185
Action Date Notes Link
article xml file uploaded 11 January 2020 10:09 CET Update https://www.mdpi.com/2072-6694/12/1/185/xml
article xml uploaded. 11 January 2020 10:10 CET Update https://www.mdpi.com/2072-6694/12/1/185/xml
article pdf uploaded. 11 January 2020 10:10 CET Updated version of record https://www.mdpi.com/2072-6694/12/1/185/pdf
article html file updated 11 January 2020 10:11 CET Update https://www.mdpi.com/2072-6694/12/1/185/html
article html file updated 6 February 2020 17:26 CET Update https://www.mdpi.com/2072-6694/12/1/185/html
article html file updated 15 February 2020 02:07 CET Update https://www.mdpi.com/2072-6694/12/1/185/html
Back to TopTop